What The Papers Say: Eczema: Studies for new treatment

We face a very exciting and very optimistic time in the treatment of eczema, or atopic dermatitis (AD). Initially we thought eczema -- an inflammatory skin disease that affects four to seven percent of adults, and 15 to 25 percent of children worldwide (with the highest numbers in Asia) -- was caused by defects in the epidermal skin barrier, or the outer layer of the skin. Now we know that eczema is an immune-driven disease that in turn causes secondary defects in the epidermal barrier.

To read more about this article, please follow this link to the Huffpost website.

See more eczema-related news headlines on What The Papers Say.